M-Power New York City:
October 1, 2022
Know the risks and symptoms of multiple myeloma, the most common blood
cancer in African Americans, and how to get the best care.
In collaboration with Memorial Sloan Kettering Cancer Center
with support from:
2seventy bio, Amgen, Bristol Myers Squibb, Genentech, GlaxoSmithKline, Janssen, Karyopharm Therapeutics, Pfizer, Takeda Oncology, The Binding Site
M-Power New York
The M-POWER project is partnering with cities across the country to turn the core vision of the IMF Diversity Initiative into a reality: improving the short- and long-term outcomes of African-American patients with multiple myeloma.